Neuroscience
From The Guardian:
'Dramatic' breakthrough in MS research
Scientists find a substance called galanin is resistant to a multiple sclerosis-like disease in both mice and human brain tissue
The Guardian
24 August 2009
Read the article
About a research finding from a neuroscience team at the University of Bristol.
- Business World: Novartis, Multiple Sclerosis, Fty720, & Betaseron
From The Wall Street Journal's Health Blog: AUGUST 17, 2009, 11:12 AM ET Novartis’s Big Plans for Multiple Sclerosis By Jeanne Whalen [snippet] The FDA gave Novartis the green light today to start selling a copy of Betaseron, the multiple sclerosis...
- Business World: Biogen Idec, Elan, Tysabri (natalizumab), And Multiple Sclerosis
From Bloomberg via the New York Times:Move to Reinstate Multiple Sclerosis Drug Published: September 21, 2005 By Bloomberg News Biogen Idec Inc. and the Elan Corporation said yesterday that they would seek federal regulatory approval to resume sales...
- More M.s. Drug Woes: Avonex And 683699
Biogen and F.D.A. Issue Drug Warning By ANDREW POLLACK The New York Times Published: March 17, 2005 Biogen Idec's multiple sclerosis drug Avonex might cause severe liver damage in rare cases, the company and the Food and Drug Administration said...
- Multiple Sclerosis And Tysabri: Fda
From the FDA: FOR IMMEDIATE RELEASE P04-107 November 23, 2004 Full press release Media Inquiries: 301-827-6242 Consumer Inquiries: 888-INFO-FDA First Monoclonal Antibody Treatment For Multiple Sclerosis Approved FDA today licensed a...
- Multiple Sclerosis And Antegren/tysabri
From the CBC:Health Canada fast tracks review of multiple sclerosis drug Last Updated Mon, 22 Nov 2004 21:28:46 EST TORONTO - Some Canadians with multiple sclerosis are encouraged by the early results of a study on a new kind of treatment for the...
Neuroscience
Galanin and Multiple Sclerosis
From The Guardian:
'Dramatic' breakthrough in MS research
Scientists find a substance called galanin is resistant to a multiple sclerosis-like disease in both mice and human brain tissue
The Guardian
24 August 2009
Read the article
About a research finding from a neuroscience team at the University of Bristol.
- Business World: Novartis, Multiple Sclerosis, Fty720, & Betaseron
From The Wall Street Journal's Health Blog: AUGUST 17, 2009, 11:12 AM ET Novartis’s Big Plans for Multiple Sclerosis By Jeanne Whalen [snippet] The FDA gave Novartis the green light today to start selling a copy of Betaseron, the multiple sclerosis...
- Business World: Biogen Idec, Elan, Tysabri (natalizumab), And Multiple Sclerosis
From Bloomberg via the New York Times:Move to Reinstate Multiple Sclerosis Drug Published: September 21, 2005 By Bloomberg News Biogen Idec Inc. and the Elan Corporation said yesterday that they would seek federal regulatory approval to resume sales...
- More M.s. Drug Woes: Avonex And 683699
Biogen and F.D.A. Issue Drug Warning By ANDREW POLLACK The New York Times Published: March 17, 2005 Biogen Idec's multiple sclerosis drug Avonex might cause severe liver damage in rare cases, the company and the Food and Drug Administration said...
- Multiple Sclerosis And Tysabri: Fda
From the FDA: FOR IMMEDIATE RELEASE P04-107 November 23, 2004 Full press release Media Inquiries: 301-827-6242 Consumer Inquiries: 888-INFO-FDA First Monoclonal Antibody Treatment For Multiple Sclerosis Approved FDA today licensed a...
- Multiple Sclerosis And Antegren/tysabri
From the CBC:Health Canada fast tracks review of multiple sclerosis drug Last Updated Mon, 22 Nov 2004 21:28:46 EST TORONTO - Some Canadians with multiple sclerosis are encouraged by the early results of a study on a new kind of treatment for the...